Israel’s Alpha Tau Medical (see here previously) has treated its first patient with recurrent lung cancer using its innovative Alpha DaRT® alpha-radiation cancer therapy. The WHO reports 2.5 million new lung cancer cases annually and the most cancer-related deaths. https://www.ourcrowd.com/startup-news/alpha-tau-treats-first-patient-with-recurrent-lung-cancer … Continue reading →

The Alpha DaRT innovative alpha-radiation cancer therapy from Israel’s Alpha Tau (see here previously) has been used to treat a liver cancer patient in a Canadian clinical trial. The trial will include up to 10 patients with liver metastases (secondary … Continue reading →

Israel’s Alpha Tau Medical uses alpha radiation to treat various types of solid tumors. Alpha DaRT (Dіffusіng Alpha-emіtters Radіatіon Therapy), developed at Tel Aviv University, is to begin clinical trials in Massachusetts USA. https://www.calcalistech.com/ctech/articles/0,7340,L-3744829,00.html https://www.massdevice.com/alpha-tau-wins-approval-to-test-cancer-targeting-device-in-the-u-s/ https://www.alphatau.com/ https://www.youtube.com/embed/ja2UQdFOueM?rel=0

Israel’s Alpha Tau (see here previously) has used its Alpha DaRT technology to treat the first Israeli patient with advanced inoperable pancreatic cancer in a clinical trial at Hadassah Medical Center in Jerusalem. https://www.alphatau.com/single-post/alpha-tau-treats-first-patient-with-advanced-inoperable-pancreatic-cancer-at-israel-s-hadassah-medic

Following the 100% success of Israel’s Alpha TAU’s last clinical trial of Alpha DaRT on recurring skin cancer (see here previously) medical institutes around the world are clamoring to participate in the upcoming pivotal trials. Alpha TAU has also begun … Continue reading →

A small trial of Alpha DaRT from Israel’s Alpha Tau (see here previously) was 100% successful in treating 10 patients with skin cancer. All were 100% clear at 12 weeks with no recurrence or toxicities in 24 weeks. https://www.globenewswire.com/news-release/2023/05/11/2667240/0/en/Alpha-Tau-Announces-the-Publication-of-its-US-Multicenter-Pilot-Skin-Cancer-Trial-Results-in-JAMA-Network-Open.html https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2804784

Israel’s Alpha Tau Medical (see here previously) has used its Alpha DaRT radiation therapy to treat its first patient with advanced inoperable pancreatic cancer. The Montreal trial will treat 30 patients with Stage II, III, or IV pancreatic cancer or … Continue reading →

Please read newsletter reader Lili Eylon’s personal account of Alpha DaRT radiation cancer therapy developed by Israel’s Alpha Tau (see here previously). Lili was one of 56 patients in DaRT’s human study at Hadassah Medical Center – its second skin … Continue reading →

Israel’s Alpha Tau Medical (see here previously) has successfully treated a patient with aggressive prostate cancer using alpha-radiation – injecting a radioactive isotope into the tumor. Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) destroys a tumor by breaking its DNA. https://nocamels.com/2022/06/israeli-researchers-use-breakthrough-tech-to-treat-prostate-cancer-for-first-time/

The 2020 OurCrowd Global Investor Summit attracted a record 23,000 delegates from 186 countries. They heard about three Israeli medical startups – Insightec, Alpha Tau and Surgical Theater and three of the patients whose lives they had saved with their … Continue reading →